The US Meals and Drug Administration has really useful a “pause” to the rollout of the Johnson & Johnson COVID vaccine so it will possibly examine experiences of blood clots.
Officers say they’re trying into six reported instances “of a uncommon & extreme kind of blood clot in people after receiving the vaccine”.
“Proper now, these antagonistic occasions seem like extraordinarily uncommon,” the FDA stated in an announcement on Twitter.
It stated till the instances had been assessed for his or her potential significance, “we’re recommending this pause”.
“That is essential to make sure that the well being care supplier neighborhood is conscious of the potential for these antagonistic occasions and might plan as a result of distinctive remedy required with such a blood clot,” it added.